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Abstract
Introduction: Dyspnoea and decreased exercise tolerance are symptoms of acute exacerbation of chronic obstructive pul- 
monary disease (AECOPD). Anaemia is a risk factor for reduced functional capacity and dyspnoea in stable COPD. There is 
limited information about the impact of anaemia on functional capacity and dyspnoea of patients during AECOPD. The aim 
of this study was to evaluate the impact of decreased blood haemoglobin concentration on the results of six-minute walking 
test (6MWT) in patients during AECOPD.
Material and methods: A post hoc analysis of data collected from prospective long-term studies on AECOPD. Haemoglobin 
concentration from the first obtainable hospital measurement were included in the assessment. 6MWT was performed after 
clinical improvement of the patient. Dyspnoea at baseline and after exercise and oxygen saturation (SpO2) during exercise 
was measured. Results: (presented as means ± SD): 402 patients with exacerbation of COPD (COPD stage 3.5 ± 0.6) were 
examined. Patients with anaemia (26% of those studied, age 74.5 ± 8.2 years) achieved 258.1 ± 125.1 m during 6MWT, 
with exertional desaturation of 2.9 ± 2.6%. Patients without anaemia (74% of those studied, age 70.2 ± 8.7 years) achieved 
271 ± 136.0 m during 6MWT with exertional desaturation of 3.8 ± 3.7%. The haemoglobin concentration did not correlate 
with 6MWT, dyspnoea during 6MWT, or exercise oxygenation and blood desaturation during exercise.
Conclusion: Mildly decreased blood haemoglobin concentration did not influence the results of 6MWT in patients with AECOPD.
Key words: COPD, anaemia, exercise test, dyspnoea
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Streszczenia
Wstęp: Duszność i zmniejszenie tolerancji wysiłku są objawami zaostrzenia przewlekłej obturacyjnej choroby płuc (POChP). 
Niedokrwistość stanowi czynnik ryzyka obniżonej tolerancji wysiłku i duszności w stabilnej POChP. Mało jest danych na 
temat wpływu niedokrwistości na tolerancję wysiłku i duszność u chorych z zaostrzeniem POChP. Celem pracy była ocena 
wpływu obniżonego stężenia hemoglobiny we krwi na wyniki 6-minutowego testu chodu (6MWT) u pacjentów w trakcie 
zaostrzenia POChP.
Materiał i metody: Retrospektywna analiza danych zebranych w trakcie badania u chorych z zaostrzeniem POChP. Do oceny 
wykorzystano pierwsze dostępne oznaczenia stężenia hemoglobiny, wykonane w trakcie hospitalizacji. 6MWT wykonano 
po uzyskaniu poprawy klinicznej pacjenta. Nasilenie duszności oceniano przed oraz po 6MWT. W trakcie 6MWT mierzono 
saturację krwi tlenem (SpO2).
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Introduction
Chronic obstructive pulmonary disease (COPD) is 
one of the most common chronic diseases worldwide, 
and its incidence is constantly rising [1]. Dyspnoea is 
one of the main disease symptoms, with primary pre-
sentation exclusively during exertion [2]. Exertional 
dyspnoea occurs usually after longstanding disease 
course, when progressing airflow limitation has beco-
me irreversible, and forced expiratory volume at one 
second (FEV1) is about 50% of the expected value 
[2]. Disturbances in respiratory mechanics are the 
main cause of dyspnoea in COPD. These are due to 
restricted airflow within the respiratory tract (obtura-
tion) and hyperinflation of lung parenchyma, leading 
to air trapping phenomena. Marked hyperinflation 
during physical exertion, also referred to as “dynamic 
hyperinflation”, is currently believed to represent the 
main pathogenetic mechanism of developing exer-
tional dyspnoea [3]. Chronic obstructive pulmonary 
disease is an inflammatory process, with occurrence 
of many systemic symptoms and signs and frequent 
coincidence of other diseases. The latter include, 
among others, anaemia and progressive cachexia, 
caused mainly by loss of muscle mass [4]. Anaemia 
in patients with COPD is of the chronic disease type, 
most likely deriving from a long-lasting systemic in-
flammatory condition.
The impact of low haemoglobin concentra-
tion on dyspnoea in patients with COPD was 
investigated in the search for possible therapeutic 
interventions in this population. One of these 
studies concerned patients with stable disease, 
in whom decreased haemoglobin concentration 
correlated with increased dyspnoea reported by 
the patients [5]. There are, however, no reports in 
the literature concerning the influence of anemia 
on the exertional dyspnoea and exercise tolerance, 
during COPD exacerbation. 
Aim
The aim of the presented study was to eva-
luate the potential impact of low haemoglobin 
concentration in the blood of patients with COPD 
Wyniki: Zbadano 402 pacjentów z zaostrzeniem POChP (średnie stadium wg PTChP 3,5 ± 0,6). Chorzy z niedokrwistością 
(26% zbadanych, wiek średni 74,5 ± 8,2 roku) w teście chodu pokonali 258,1 ± 125,1 m, z desaturacją wysiłkową na po- 
ziomie 2,9 ± 2,6%. Chorzy bez niedokrwistości (74% zbadanych, wiek średni 70,2 ± 8,7 roku) w teście chodu pokonali 271
± 136 m, z desaturacją wysiłkową na poziomie 3,8 ± 3,7%. Stężenie hemoglobiny nie korelowało z 6MWT, dusznością po 
6MWT, saturacją w trakcie wysiłku i desaturacją krwi po wysiłku.
Wnioski: Łagodnie obniżone stężenie hemoglobiny we krwi nie wpływało na wyniki 6MWT u pacjentów z zaostrzeniem POChP.
Słowa kluczowe: POChP, niedokrwistość, test wysiłkowy, duszność
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exacerbation upon exertional dyspnoea and on the 
results of six-minute walking test (6MWT). 
Material and methods
The study was based on post hoc analysis 
of the results of functional tests collected on 
a prospective basis as part of a single cen-
tre study, focusing on predictive factors in 
COPD. Tests were performed in patients with 
COPD exacerbation, hospitalized in the 2nd De-
partment of  Respiratory Diseases of  the 
National Tuberculosis and Lung Diseases Rese-
arch Institute. Diagnostic criteria of COPD were 
adopted from the guidelines published by PTChP 
(Polish Society for Lung Diseases) [2]. Excluded 
from the study were patients in whom 6MWT 
and spirometry could not be performed. In all the 
included subjects, diagnostic tests were performed, 
including morphological analysis of periphe-
ral blood, 6MWT with assessment of exertional 
dyspnoea according to the pending guidelines 
[6], and spirometry. Test results were collected on 
a prospective basis. As spirometry was performed 
during regression of disease exacerbation, usually 
a couple of days after admission to hospital, the 
results did not reflect true values of lung volume 
in the analysed patients. Spirometry results were 
therefore not included in the final statistical analy-
sis. Nevertheless, patient stratification according to 
the disease severity could be performed based on 
the obtained results of forced expiratory volume 
in one second (FEV1), measured after inhalation 
of a broncholytic agent. The analysed parameters 
included haemoglobin concentration in peripheral 
blood, as well as blood gas analysis performed in 
arterialized venous blood, both sampled directly 
on admission. Forty-one of the studied patients 
with COPD had longstanding oxygen therapy at 
home. Those included persons with reduced blood 
haemoglobin level (2 patients) and subjects with 
normal haemoglobinaemia (20 persons). It was 
initially planned that patients remaining on oxygen 
therapy should not be included in final analysis, 
since this therapeutic modality affects tolerance 
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to physical activity in COPD. However, data con-
cerning these subjects were finally included in the 
study, as tolerance of exertion is influenced not 
only by oxygen therapy but also by numerous other 
factors, including patient age, fitness, body mass, 
or concomitant diseases. Separate analysis of data 
concerning patients on oxygen therapy was not 
possible due to the low number of these subjects.
Six-minute walking test (6MWT) was perfor- 
med several days after admission to hospital, when 
major symptoms and signs of disease exacerbation 
were under control, and the patient was clinically 
stable. The test was performed in a 50-meter-long 
corridor. Classification of perceived dyspnoea 
developed by Borg [7] was used for assessment of 
shortness of breath at rest, exertional dyspnoea, 
and feeling of dyspnoea after completion of the 
test. Continuous percutaneous measurement of 
peripheral blood saturation, and heart rate, was 
performed using a portable pulseoximeter during 
the entire 6MWT. Patients requiring oxygen therapy 
in hospital were breathing oxygen provided at the 
same flow rate as before the test or increased by 
0.5–1 litre per minute, according to the orders of 
their treating physician. In both studied patients 
groups there were similar percentages of patients 
requiring oxygen therapy. These patients were 
not excluded from final analysis and no separate 
analysis was performed in this subpopulation as the 
low patient number and the overall study aim were 
considered. Based on the results of haemoglobin 
concentration analysis in peripheral blood, anaemia 
was diagnosed according to the respective World 
Health Organisation (WHO) criteria [8]. Anaemia 
was assigned when haemoglobin concentration was 
below 12 g/dL in women and below 13 g/dL in men.
Statistical analysis
Statistical analysis was performed using 
SigmaPlot 11 software (USA). Basic descriptive 
parameters were compared between the groups 
of patients with low haemoglobin concentration 
or with normal haemoglobinaemia. Descriptive 
statistical data are presented in tables as mean 
and standard deviation values. For comparisons 
between the groups, Student’s t-test or Mann-Wil- 
coxon rank sum test were used, depending on the 
normal or non-normal distribution of parameters. 
The relative numbers of patients in groups were 
analysed using the chi square test. A statistical si- 
gnificance level was adopted for p < 0.05. Analysis 
of linear regression was performed for assessment 
of relationships between functional parameters and 
haemoglobin levels in peripheral blood.
Results
The entire analysed study population included 
464 patients, of which 62 were excluded due to lack 
of complete data. Final analysis included data con- 
cerning 402 patients, including 165 women (41%) 
and 237 men (59%), for whom complete clinical 
and laboratory data were available.
Mean haemoglobin concentration in the stu- 
died patient group was 14.0 ± 1.7 g/L, and mean 
haematocrit was 43.5 ± 5.7. Decreased haemoglo- 
bin concentration was found in 104 patients (26% 
of all subjects).
Basic patient characteristics are presented in 
Table 1.
There were 54% women in the patient group 
with low haemoglobin levels, and 47% in the gro-
up with normal haemoglobin concentration; the 
diffe- rence was not statistically significant. These 
two groups did not differ according to disease se-
verity classified according to PTChP. Patients with 
anaemia had significantly higher partial oxygen 
pressure in the arterialized venous blood. 
Patients with COPD who had low haemoglobin 
concentration were significantly older (74.5 ± 8.2 
years) than subjects with normal haemoglobin le-
vels (70.2± 8.7 years). Patients with anaemia also 
had lower haematocrit as compared to patients 
with normal haemoglobin concentration, with 
respective median values of 37.3% (35.7–39.1%) 
and 44.9% (42.6–48.4%); p < 0.001.
Results of the 6MWT are presented in Table 2.
Decreased haemoglobin concentration in COPD 
patients did not affect the results obtained in the 
six-minute walking test. Patients with COPD and 
anaemia walked a similar distance during the test 
as persons with normal haemoglobin concentration.
Low haemoglobin levels in the investigated 
patients did not significantly contribute to a feeling 
of breathlessness. A similar degree of dyspnoea was 
reported by patients in both groups before the test, 
with increasing shortness of breath after exertion, 
though with no major differences between the gro-
ups. Patients with anaemia had significantly higher 
oxygen blood saturation (SpO2) before the test and 
less decrease of SpO2 on exertion as compared to 
subjects with normal haemoglobin levels.
Analysis of linear regression revealed no cor- 
relation between dyspnoea arising on exertion or 
dyspnoea increase in Borg scale and blood haemoglo- 
bin concentration (correlation coefficient = 0.0687, 
standard error = 0.0638, t = –1.077, p = 0.282).
The greatest percentage of patients with ana-
emia was observed in the group with stage II COPD 
(35%). Fewer patients with more severe COPD 
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were anaemic (28% subjects with stage III, 13% of 
patients with stage IV disease) (Tab. 3).
Percentage of patients with COPD and ana-
emia increased with patients’ age (Fig. 1). Pearson 
correlation analysis showed a strong relationship 
between age and haemoglobin concentration (R = 
–0.23; p = 0.00000613).
Discussion
The presented study confirms that low hae- 
moglobin concentration, a crucial sign of anaemia, 
is a common phenomenon in patients with COPD. 
However, the definition of anaemia in this  popu-
lation and threshold levels of blood haemoglobin 
concentration should be reconsidered. The World 
Health Organisation criteria of anaemia [8] applied 
in this study are often used in epidemiological 
studies, thanks to their simplicity and availability 
of numerous reference publications. The applica-
tion of WHO criteria permits comparison of the 
incidence of anaemia in various populations and 
enables the assessment of the worldwide prevalen-
ce of this aberration. Studies based on the WHO 
definition of anaemia estimate that in Europe 8% 
of persons over 60 years of age (i.e. of similar age 
as the patients described in the presented study) 
are anaemic. American data state that as many as 
10.6% of elderly persons have low haemoglobin 
concentration [9]. The percentage of patients with 
stable COPD and anaemia reported by Chambellan 
et al. [10] was higher (12%). The presented analysis 
does not fulfill criteria of an epidemiological study, 
and it was performed in a exertional dyspnoea, and 
is widely used in exercise tests. This scale was de-
veloped by Borg [7] and is applied in the presented 
study. The timing of the exercise test should also 
be mentioned here. The current study concerned 
Table 1. Patient characteristics in the study population
Variable Patients with low haemoglobin 
concentration (%)
Patients with normal haemoglobin 
concentration (%)
p value
Number of patients (n = 402) 104 (26%) 298 (74%) p < 0.001
Sex (M/F) Men (M) 48 (46%) Men (M) 189 (63%) p = 0.108
Women (F) 56 (54%) Women (F) 109 (47%)
Age (years) 74.5 ± 8.2 70.2 ± 8.7 p < 0.001
Haemoglobin concentration  
(g/dL)
11.9 ± 0.9 14.8 ± 1.3 p < 0.001
FEV1 (L) 0.96±0.52 0.94 ± 0.48 p = 0.721
FEV1 (% of the predicted value) 35.6 ± 16.8 34.8 ± 19.6 p = 0.711
PaO2 (mm Hg) 63.3 ± 13.8 60.2 ± 11.9 p = 0.023
PaCO2 (mm Hg) 45.6 ± 10.7 47.0 ± 10.6 p = 0.258
pH 7.399 ± 0.217 7.370 ± 0.270 p = 0.348
Table 2. Six-minute walking test results in patients with COPD by haemoglobin concentration
Variable Patients with low haemoglobin 
concentration
Patients with normal haemoglobin 
concentration
p value
6MWT distance (m) 258.1 ± 125 271.3 ± 136.0 p = 0.389
SpO2 before 6MWT (%) 94.6 ± 2.2 93.9 ± 3.1 p = 0.048
Desaturation (ΔSpO2,%) 2.9 ± 2.6 % 3.8 ± 3.7 % p = 0.048
Dyspnoea before 6MWT  
(according to Borg scale)
0.4 ± 0.9 0.5 ± 1.0 p = 0.513
Dyspnoea after 6MWT  
(according to Borg scale)
2.5 ± 2.5 2.2 ± 2.4 p = 0.309
Dyspnoea Δ (dyspnoea increase; 
according to Borg scale)
2.1 ± 2.3 1.7 ± 2.2 p = 0.154
www.pneumonologia.viamedica.pl
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Table 3. Patients with COPD and anaemia or normal haemoglobin concentration by COPD severity
Patients with respective COPD 
stages according to PTChP
Patients with low haemoglobin 
concentration
Patients with normal haemo-
globin concentration
p value
Stage I, n = 0 n = 0 n = 0
Stage II, n = 31 n = 11 (35%) n = 20 (65%) p < 0.001
Stage III, n = 125 n = 35 (28%) n = 90 (72%)
Stage IV, n = 216 n = 29 (13%) n =187 (87%)
patients hospitalised due to exacerbation of COPD. 
Exercise tests were not performed on the day of 
patient admission, due to clinical concerns, but 
were carried out after several days of treatment. 
However, as each COPD exacerbation is a process 
lasting usually for over 10 days, it can be stated 
that six-minute walking tests  were actually per-
formed during the disease exacerbation phase in 
the analysed patients [12].
Severe anaemia causes clinically notable 
dyspnoea due to tissue hypoxia, compensatory 
tachycardia, and tachypnoea. In cases of COPD 
exacerbation, anaemia is not a major cause of 
breathlessness and other causes population of pa-
tients experiencing a particular event in the course 
of the disease (exacerbation of COPD). However, 
a significant amount of patients (26%) in the stu-
died population had signs of anaemia.
The main aim of the presented study was to 
search for potential correlations between anaemia 
in patients with COPD and dyspnoea, as well as 
tolerance to physical exercise. The assessment of 
patient-reported shortness of breath most often 
refers to the MRC scale [11], which is easy to use 
and reproducible. This scale can be used for eva-
luation of dyspnoea over a longer period of time 
(e.g. a week or a month). Another scale is better 
suited for investigation of exertional dyspnoea, 
and is widely used in exercise tests. This scale 
was developed by Borg [7] and is applied in the 
presented study. The timing of the exercise test 
should also be mentioned here. The current study 
Figure 1. Patients with COPD and anaemia or normal haemoglobin concentration by age groups
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concerned patients hospitalised due to exacerba-
tion of COPD. Exercise tests were not performed 
on the day of patient admission, due to clinical 
concerns, but were carried out after several days of 
treatment. However, as each COPD exacerbation is 
a process lasting usually for over 10 days, it can be 
stated that six-minute walking tests were actually 
performed during the disease exacerbation phase 
in the analysed patients [12].
Severe anaemia causes clinically notable dysp-
noea due to tissue hypoxia, compensatory tachycar-
dia, and tachypnoea. In cases of COPD exacerbation, 
anaemia is not a major cause of breathlessness and 
other causes of dyspnoea play more important roles 
in the development of this symptom [3].
There are few studies published on the effect 
of anaemia on exercise tolerance in patients with 
COPD. Cote et al. studied patients with stable 
COPD and observed that the presence of anaemia 
affects, in general, the feeling of breathlessness 
measured in the MRC scale [5]. However, these 
authors did not analyze particularly dyspnoea on 
exertion, measuring only the general feeling of 
dyspnoea. Their conclusion was that anaemia de- 
creases tolerance of exercise measured in 6MWT. 
However, there was no such correlation in the pre- 
sented study. Discrepant results of the two studies 
can possibly be explained by the timing of patient 
assessment, since in the presented study dyspnoea 
was analysed during episodes of COPD exacerba- 
tion, whereas Cote and al. analysed patients with 
stable disease. It may therefore be implied that the- 
rapeutic intervention of compensating anaemia 
in order to decrease the feeling of dyspnoea, as 
proposed by Cote and al., may not have any major 
effect in the treatment of COPD exacerbations.
The differences between the groups in  partial 
oxygen pressure of arterialized venous blood and 
blood oxygen saturation measured percutaneously 
also require some attention. Patients with normal 
haemoglobin concentration had significantly 
lower partial oxygen pressure and oxygen blood 
saturation before the exercise test, despite the fact 
that the percentage of patients on oxygen therapy 
was similar in both studied groups.  This finding 
may be explained by some of the methodological 
limitations of the presented study. Saturation 
was measured in the standard way, by blood gas 
analysis and by percutaneous assessment of oxy-
gen blood saturation (SpO2). The lower amount of 
circulating haemoglobin in patients with anaemia 
was probably oxygenated more quickly in the lun-
gs, thus producing higher oxygen saturation levels 
measured percutaneously. At the same time, lower 
oxygen absorption by haemoglobin resulted in the 
increase of oxygen amount dissolved in plasma, 
causing increased PaO2.
The highest percentage of anaemic patients
was found in the group with stage II COPD. In 
order to explain this  mechanism, further studies 
would be necessary, including assessment of in-
flammation parameters. Most recent publications 
emphasise that anaemia in patients with COPD 
is of the chronic disease type, due to a systemic 
inflammatory process or, less likely, because of 
disturbed iron metabolism [13].
In the presented study there was no corre-
lation between low haemoglobin concentration, 
exertional dyspnoea, and blood oxygen saturation 
measured percutaneously on exertion. However, 
anaemia correlated with patient age, which is in 
accordance with observations published by Gu-
ralnik [9], who noted a much higher incidence of 
anaemia in elderly patients.
To sum  up, the presented study suggests that 
the mild decrease in haemoglobin concentration 
observed in some patients with COPD is not 
a major cause of increasing dyspnoea and decreased 
exercise tolerance during disease exacerbations
Conclusions
Patients with COPD and a mild decrease in ha- 
emoglobin concentration did not experience more 
dyspnoea on exertion during disease exacerbations 
as compared to patients with normal haemoglobin 
levels. Similarly, anaemia did not significantly 
contribute to shorter walking distance in 6MWT 
in patients with COPD exacerbation. Patients with 
COPD and anaemia were significantly older than 
subjects having normal haemoglobin concentration 
according to WHO criteria.
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